Keywords
Bronquiolite
Pediatria
How to Cite
Abstract
Acute Viral Bronchiolitis (AVB) is a common respiratory infection in infants, with Respiratory Syncytial Virus (RSV) being the main etiological agent. The disease can progress to severe cases, requiring hospitalization, especially in high-risk groups. Diagnosis is clinical, with advances in PCR usage. Treatment is supportive, and new strategies, such as immunoprophylaxis, are being studied. Research suggests a possible link between AVB and future respiratory diseases, reinforcing the need for management and prevention strategies. This study aims to explore recent advances in the diagnosis, treatment, and prevention of AVB. The Scielo and PubMed indexers were used as search engines for article selection, with the keywords “Acute Bronchiolitis; Bronchiolitis; Pediatrics.” It is concluded that acute viral bronchiolitis is a common and challenging respiratory infection in pediatrics, especially in infants and vulnerable groups. Diagnosis, enhanced by technologies such as RT-PCR, aids in identifying viral agents. Treatment is supportive, avoiding unnecessary interventions. The disease may increase the risk of childhood asthma, requiring further research. Preventive strategies, such as palivizumab and hygiene measures, are essential. Scientific advances may lead to new approaches, reducing the impact of bronchiolitis and improving pediatric care.
References
CASTRO-RODRIGUEZ, J. A. et al. A clinical index to define risk of asthma in young children with recurrent wheezing. American Journal of Respiratory and Critical Care Medicine, v. 162, n. 4, p. 1403-1406, 2000.
DE ANDRADE, Naysa Gabrielly Alves et al. Bronquiolite Viral Aguda: um panorama completo da definição, epidemiologia, fisiopatologia, sintomas, tratamento e desfecho. Brazilian Journal of Implantology and Health Sciences, v. 6, n. 7, p. 2430-2442, 2024.
FELTES, T. F. et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. Journal of Pediatrics, v. 143, n. 4, p. 532-540, 2003.
GADOMSKI, A. M.; SCRIBANI, M. B. Bronchodilators for bronchiolitis. Cochrane Database of Systematic Reviews, n. 6, CD001266, 2014.
HALL, C. B. et al. The burden of respiratory syncytial virus infection in young children. New England Journal of Medicine, v. 360, n. 6, p. 588-598, 2009.
LANARI, M. et al. Respiratory syncytial virus infections in infants affected by primary immunodeficiency. Journal of Translational Medicine, v. 18, n. 1, p. 1-12, 2020.
MEISSNER, H. C. Viral bronchiolitis in children. New England Journal of Medicine, v. 374, n. 1, p. 62-72, 2016.
MIDULLA, F. et al. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Archives of Disease in Childhood, v. 95, n. 1, p. 35-41, 2010.
RALSTON, S. L. et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics, v. 134, n. 5, p. e1474-1502, 2014.
WISHHAUPT, J. O. et al. Clinical impact of RT-PCR for pediatric acute respiratory infections: a controlled clinical trial. Pediatric Pulmonology, v. 46, n. 6, p. 532-539, 2011.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Amandha Wei de Souza, Luíza Fricks Cabellino, Mariana Campos Barbieri, Pedro Gabriel Cazotti Thiengo, Alan Marcelo Volpato, Vinicius Fernandes Friedrich, Lilian Castilho Simão, Daniely Saraiva Pimentel, Anna Cecília Santos Pereira, Jeimile Aiala Mota Freitas